Arata Osanami Masatoshi Kanda Tatsuya Sato Chikako Akazawa Shuhei Baba Hiroaki Komatsu Kazuyuki Murase Tomohisa Yamashita Toshiyuki Yano
10.3389/fendo.2022.997296
Front Endocrinol (Lausanne)
2022 Sep 9;13:997296.
sjögren’s syndrome catabolism double-filtration plasma apheresis ketosis rituximab sensor-augmented pump (sap) systemic lupus erythematosus type b insulin resistance (tbir)
CC BY
https://pubmed.ncbi.nlm.nih.gov/36157458/
Autoimmune Diseases Diabetes Mellitus / drug therapy Hyperglycemia / complications Insulin Resistance Lupus Erythematosus, Systemic / complications
Autoimmune Diseases Diabetes Mellitus / drug therapy Hyperglycemia / complications Insulin Resistance Lupus Erythematosus, Systemic / complications Case Reports Research Support, Non-U.S. Gov't Aged Antibodies, Monoclonal / therapeutic use Autoantibodies Glucocorticoids / therapeutic use Humans Hypoglycemic Agents / therapeutic use Immunosuppressive Agents / therapeutic use Male Plasmapheresis Rituximab / therapeutic use Antibodies, Monoclonal Autoantibodies Glucocorticoids Hypoglycemic Agents Immunosuppressive Agents Rituximab
PMC9500182
36157458
Case report: Successful combination therapy with double-filtration plasmapheresis and rituximab under the condition of the use of a sensor-augmented pump for type B insulin resistance syndrome
2022